These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 36313430)
1. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma. Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M Front Genet; 2022; 13():794621. PubMed ID: 36313430 [No Abstract] [Full Text] [Related]
2. A Novel Glycolysis-Related Long Noncoding RNA Signature for Predicting Overall Survival in Gastric Cancer. Zeng J; Li M; Dai K; Zuo B; Guo J; Zang L Pathol Oncol Res; 2022; 28():1610643. PubMed ID: 36419649 [No Abstract] [Full Text] [Related]
3. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
4. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma. Song Z; Su M; Li X; Xie J; Han F; Yao J BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437 [TBL] [Abstract][Full Text] [Related]
5. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer. Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844 [TBL] [Abstract][Full Text] [Related]
6. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
7. Construction and validation of a prognostic signature for mucinous colonic adenocarcinoma based on N7-methylguanosine-related long non-coding RNAs. Gao Y; Ren J; Chen K; Guan G J Gastrointest Oncol; 2024 Feb; 15(1):203-219. PubMed ID: 38482248 [TBL] [Abstract][Full Text] [Related]
8. Identification of a Novel Glycolysis-Related LncRNA Signature for Predicting Overall Survival in Patients With Bladder Cancer. Zheng Z; Lai C; Li W; Zhang C; Ma K; Yao Y Front Genet; 2021; 12():720421. PubMed ID: 34490046 [TBL] [Abstract][Full Text] [Related]
9. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer. Wang L; Xiao K; Dong Z; Meng T; Cheng X; Xu Y J Cancer Res Clin Oncol; 2023 Sep; 149(12):10543-10559. PubMed ID: 37291405 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a novel cellular senescence-related lncRNA prognostic signature for predicting immunotherapy response in stomach adenocarcinoma. Zeng C; Liu Y; He R; Lu X; Dai Y; Qi G; Liu J; Deng J; Lu W; Jin J; Liu Q Front Genet; 2022; 13():935056. PubMed ID: 36092903 [No Abstract] [Full Text] [Related]
11. A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma. Luo L; Li L; Liu L; Feng Z; Zeng Q; Shu X; Cao Y; Li Z Front Genet; 2022; 13():833928. PubMed ID: 35330731 [No Abstract] [Full Text] [Related]
12. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R Front Immunol; 2022; 13():854785. PubMed ID: 35392086 [TBL] [Abstract][Full Text] [Related]
13. The necroptosis-related signature and tumor microenvironment immune characteristics associated with clinical prognosis and drug sensitivity analysis in stomach adenocarcinoma. Yang B; Wang Y; Liu T; Zhang M; Luo T Aging (Albany NY); 2024 Mar; 16(7):6098-6117. PubMed ID: 38546403 [TBL] [Abstract][Full Text] [Related]
14. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients. Zha Z; Zhang P; Li D; Liu G; Lu L Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217 [TBL] [Abstract][Full Text] [Related]
15. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma. Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M Front Oncol; 2021; 11():663263. PubMed ID: 34123820 [TBL] [Abstract][Full Text] [Related]
16. A novel necroptosis-related lncRNA based signature predicts prognosis and response to treatment in cervical cancer. Du X; Pu X; Wang X; Zhang Y; Jiang T; Ge Y; Zhu H Front Genet; 2022; 13():938250. PubMed ID: 36561319 [No Abstract] [Full Text] [Related]
17. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma. He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526 [TBL] [Abstract][Full Text] [Related]
18. Construction of a Nomogram Based on a Hypoxia-Related lncRNA Signature to Improve the Prediction of Gastric Cancer Prognosis. Chen Q; Hu L; Chen K Front Genet; 2020; 11():570325. PubMed ID: 33193668 [TBL] [Abstract][Full Text] [Related]
19. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma. Liu Z; Liu H; Wang Y; Li Z BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983 [TBL] [Abstract][Full Text] [Related]
20. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Ma B; Li Y; Ren Y Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]